Compare BFRI & YFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFRI | YFOR |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 18.4M |
| IPO Year | 2021 | 2023 |
| Metric | BFRI | YFOR |
|---|---|---|
| Price | $1.36 | $1.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 696.4K | 162.1K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,705,000.00 | N/A |
| Revenue This Year | $14.36 | N/A |
| Revenue Next Year | $16.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.75 | N/A |
| 52 Week Low | $0.57 | $1.22 |
| 52 Week High | $1.66 | $1.53 |
| Indicator | BFRI | YFOR |
|---|---|---|
| Relative Strength Index (RSI) | 51.98 | N/A |
| Support Level | $0.78 | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.11 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 33.31 | 0.00 |
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.